Literature DB >> 7481553

Nitric oxide synthase pathway may mediate human natural killer cell cytotoxicity.

L Xiao1, P H Eneroth, G A Qureshi.   

Abstract

The present study provides evidence that the human natural killer (NK) cell effector mechanism causing target cytolysis has a requirement for L-arginine. In a deficient medium (DM) containing only salts, buffer system and glucose, NK cell-mediated cytotoxicity was found to decrease by 70% as compared to that obtained in a complete medium (CM). However, adding L-arginine to such DM could restore the activity of NK cells to the normal level. Many other components of CM, such as serum, glutamine and vitamins did not improve NK cell-mediated killing in DM. When all amino acids except L-arginine were added to DM only a partial recovery of NK cell functional cytolysis was seen. L-arginine enhanced the NK cell activity in a dose-dependent manner. Additionally, the inhibitor of both inducible and constitutive nitric oxide synthase, N-monomethyl-L-arginine (L-NMMA) inhibited NK cytolytic activity in DM supplemented with L-arginine indicating participation of nitric oxide (NO). The results also show that the stimulatory effect of L-arginine on human NK cell-mediated cytotoxicity was accompanied by an increase in NO formation as determined by accumulation of nitrite and citrulline. L-NMMA gave a dose-dependent reduction in NO generation as well. The nitrite and citrulline production dose-dependently correlated with not only the concentration of L-arginine in the cultivation medium, but also the enhanced NK cell-mediated cytolysis. Taken together, these findings could define a L-arginine/NO-linked effector mechanism in human NK cells. Nitrite and citrulline were not formed when NK cell-mediated target cell killing took place in a L-arginine-free DM supplemented with additives. Thus, it appears as if human NK cells may cause target cell killing via both NO-dependent and -independent processes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7481553     DOI: 10.1111/j.1365-3083.1995.tb03687.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  12 in total

1.  Biochemistry of nitric oxide.

Authors:  Safia Habib; Asif Ali
Journal:  Indian J Clin Biochem       Date:  2011-02-03

2.  A recombinant vaccinia virus encoding inducible nitric oxide synthase is attenuated in vivo.

Authors:  M S Rolph; W B Cowden; C J Medveczky; I A Ramshaw
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

Review 3.  Immunological aetiology of major psychiatric disorders: evidence and therapeutic implications.

Authors:  Barbara Sperner-Unterweger
Journal:  Drugs       Date:  2005       Impact factor: 9.546

4.  A Translational Randomized Trial of Perioperative Arginine Immunonutrition on Natural Killer Cell Function in Colorectal Cancer Surgery Patients.

Authors:  Leonard Angka; Andre B Martel; Juliana Ng; Amanda Pecarskie; Manahil Sadiq; Ahwon Jeong; Marlena Scaffidi; Christiano Tanese de Souza; Michael A Kennedy; Shaheer Tadros; Rebecca C Auer
Journal:  Ann Surg Oncol       Date:  2022-07-25       Impact factor: 4.339

Review 5.  The dichotomous role of H2S in cancer cell biology? Déjà vu all over again.

Authors:  Khosrow Kashfi
Journal:  Biochem Pharmacol       Date:  2018-02-14       Impact factor: 5.858

6.  C-reactive protein, procalcitonin, interleukin-6, vascular endothelial growth factor and oxidative metabolites in diagnosis of infection and staging in patients with gastric cancer.

Authors:  Nevin Ilhan; Necip Ilhan; Yavuz Ilhan; Handan Akbulut; Mehmet Kucuksu
Journal:  World J Gastroenterol       Date:  2004-04-15       Impact factor: 5.742

7.  The transcription factor interferon regulatory factor-1 is essential for natural killer cell function in vivo.

Authors:  G S Duncan; H W Mittrücker; D Kägi; T Matsuyama; T W Mak
Journal:  J Exp Med       Date:  1996-11-01       Impact factor: 14.307

Review 8.  Dysfunctional Natural Killer Cells in the Aftermath of Cancer Surgery.

Authors:  Leonard Angka; Sarwat T Khan; Marisa K Kilgour; Rebecca Xu; Michael A Kennedy; Rebecca C Auer
Journal:  Int J Mol Sci       Date:  2017-08-17       Impact factor: 5.923

9.  iNOS Expression by Tumor-Infiltrating Lymphocytes, PD-L1 and Prognosis in Non-Small-Cell Lung Cancer.

Authors:  Alexandra Giatromanolaki; Avgi Tsolou; Eleftheria Daridou; Maria Kouroupi; Katerina Chlichlia; Michael I Koukourakis
Journal:  Cancers (Basel)       Date:  2020-11-05       Impact factor: 6.639

Review 10.  The dual role of iNOS in cancer.

Authors:  Federica Vannini; Khosrow Kashfi; Niharika Nath
Journal:  Redox Biol       Date:  2015-08-24       Impact factor: 11.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.